Vigabatrin for Treatment of Cocaine Dependence

Clinical trial NCT00611130 · COMPLETED

Trial details

NCT number: NCT00611130
Sponsor: Catalyst Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cocaine Dependence

Start date: 2008-01-01
Primary completion: 2009-05-01
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.